These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22890158)

  • 1. Drug susceptibility pattern of Mycobacterium tuberculosis isolates from patients of category-II failure of pulmonary tuberculosis under directly observed treatment short-course from north India.
    Prasad R; Verma SK; Garg R; Jain A; Anand SC; Hosmane GB; Verma RK; Kushwaha NS; Kant S
    Biosci Trends; 2012 Jun; 6(3):110-4. PubMed ID: 22890158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
    Bhatt G; Vyas S; Trivedil K
    Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining trend of resistance to first-line anti-tubercular drugs in clinical isolates of Mycobacterium tuberculosis in a tertiary care north Indian hospital after implementation of revised national Tuberculosis control programme.
    Jain A; Diwakar P; Singh U
    Indian J Med Microbiol; 2014; 32(4):430-3. PubMed ID: 25297031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
    Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.
    Mishra B; Rockey SM; Gupta S; Srinivasa H; Muralidharan S
    Trop Doct; 2012 Jan; 42(1):35-7. PubMed ID: 22080484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
    Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
    Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.